Biochemical and molecular markers in renal cell carcinoma: an update and future prospects
- 1 January 2005
- journal article
- review article
- Published by Informa UK Limited in Biomarkers
- Vol. 10 (4), 258-294
- https://doi.org/10.1080/13547500500218534
Abstract
Cancer is a big problem in the developed world as well as in developing countries. Renal cell carcinoma (RCC) accounts for approximately 3% of adult malignancies and 90-95% of neoplasms arising from the kidney. RCC is more common in men than in women (2:1), and it most often occurs in patients between the ages of 50-70 years. In all cancers the cancerous cells release particular kind of proteins (called tumour markers) and blood tests are used to detect the presence of these markers. These tumour markers nowadays are an area of interest for oncologists who search for a possible solution in the detection and treatment of RCC. Different kinds of biochemical and molecular markers such as ferritin, MN/CA9, apoptotic index, p53, IL-2, gamma-enolase, CD44, CD95, chromosome instability and loss of heterozygosity have been tested in RCC, but so far no marker fulfils one or the other criteria to be considered as an ideal marker for RCC. This review gives basic and updated information about the different kinds of biomarkers studied in RCC and about the role implementation of genomics and proteomics in RCC.Keywords
This publication has 95 references indexed in Scilit:
- Immunoreactivity of CD10 and inhibin alpha in differentiating hemangioblastoma of central nervous system from metastatic clear cell renal cell carcinomaLaboratory Investigation, 2005
- Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patientsBritish Journal of Cancer, 2004
- p21 WAF1/CIP1 is more effective than p53 in growth suppression of mouse renal carcinoma cell line Renca in vitro and in vivoZeitschrift für Krebsforschung und Klinische Onkologie, 2003
- Contribution of nitric oxide-mediated apoptosis to cancer metastasis inefficiencyFree Radical Biology & Medicine, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Erythropoietin stimulates proliferation of human renal carcinoma cellsKidney International, 2000
- MN/CA9 gene expression as a potential biomarker in renal cell carcinomaBJU International, 1999
- The effects of glucocorticoids on phorbol ester and cytokine stimulated transcription factor activation in human lungLife Sciences, 1994
- Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical levelJournal of Molecular Histology, 1986